TrialPanorama/TrialPanorama-database huggingface dataset:
Study 34190086 — Surrogate Endpoint (SUR): Bone mineral density
Study 32949103 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33135429 — Surrogate Endpoint (SUR): Blood pressure
Study 33298407 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32145830 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34158099 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33275070 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32622346 — Surrogate Endpoint (SUR): Blood pressure
Study 32023922 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32023922 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33302644 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 33302644 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32107266 — Predictive Biomarker (PRD): CXCL14 mRNA
Genes: CXCL14; MIP2G; NJAC; SCYB14; PSEC0212; UNQ240/PRO273
Study 33926653 — Surrogate Endpoint (SUR): Blood pressure
Study 32572800 — Predictive Biomarker (PRD): SLC22A18 mRNA
Genes: SLC22A18; BWR1A; BWSCR1A; HET; IMPT1; ITM; ORCTL2; SLC22A1L; TSSC5
Study 32572800 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32572800 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 36429384 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 36429384 — Surrogate Endpoint (SUR): Blood pressure
Study 36429384 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32636239 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 35303890 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 34725453 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36370176 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 36370176 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 36370176 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 32308366 — Predictive Biomarker (PRD): NUBP1 mRNA
Genes: NUBP1; NBP; NBP1
Study 33314283 — Surrogate Endpoint (SUR): Blood pressure
Study 34362522 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 34362522 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 34362522 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 34362522 — Safety Biomarker (SAF): Reactive oxygen species
Study 32244696 — Surrogate Endpoint (SUR): Blood pressure
Study 33116455 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 35716932 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33454896 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study 33454896 — Surrogate Endpoint (SUR): Serum sodium
Study 33454896 — Surrogate Endpoint (SUR): Blood pressure
Study 35238960 — Surrogate Endpoint (SUR): Serum creatinine
Study 33191588 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 34031056 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34031056 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 33293152 — Surrogate Endpoint (SUR): Blood pressure
Study 33291053 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 35379402 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 33028197 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33462485 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 35183892 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 35144596 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34275768 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 34275768 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 33845158 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 33845158 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34010805 — Surrogate Endpoint (SUR): Blood pressure
Study 35363951 — Surrogate Endpoint (SUR): Blood pressure
Study 34145478 — Predictive Biomarker (PRD): RAB11FIP1 mRNA
Genes: RAB11FIP1; RCP
Study 36309168 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36309168 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33952812 — Predictive Biomarker (PRD): S100A12 mRNA
Genes: S100A12
Study 33952812 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35819090 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 34258468 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 34258468 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34258468 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34258468 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34258468 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 34258468 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 34258468 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32690834 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 32690834 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 34873992 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 34873992 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study 33118194 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32764397 — Surrogate Endpoint (SUR): Bone mineral density
Study 34358723 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 34358723 — Safety Biomarker (SAF): BDNF
Study 35699623 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35699623 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 32691164 — Predictive Biomarker (PRD): OSR1 mRNA
Genes: OSR1; ODD
Study 35273051 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 35706495 — Surrogate Endpoint (SUR): Blood pressure
Study 34842950 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 34423625 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35213666 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 32406746 — Surrogate Endpoint (SUR): Blood pressure
Study 33544759 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33544759 — Surrogate Endpoint (SUR): Bone mineral density
Study 32887851 — Surrogate Endpoint (SUR): Blood pressure
Study 37948286 — Surrogate Endpoint (SUR): Blood pressure
Study 37948286 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33541535 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 616118509 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 616118509 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33206794 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33206794 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33971288 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 33991820 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study 36041751 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34398311 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34398311 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32929841 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35442196 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 32156696 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 32493335 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 33297608 — Safety Biomarker (SAF): Biliary glycoprotein 1
Genes: CEACAM1; BGP; BGP1
Study 32443412 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32443412 — Monitoring Biomarker (MOI): Alpha-1-acid glycoprotein 1
Genes: ORM1; AGP1
Study 36444953 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35193648 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 32173766 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35979057 — Surrogate Endpoint (SUR): Blood pressure
Study 33259540 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35502662 — Surrogate Endpoint (SUR): Blood pressure
Study 34143559 — Surrogate Endpoint (SUR): Blood pressure
Study 33834521 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 32881912 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32914866 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35616410 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34857545 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32169808 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 33978070 — Safety Biomarker (SAF): Hyaluronic acid
Study 33030584 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 35030476 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Angiotensinogen
Genes: AGT; SERPINA8
Study 35030476 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35030476 — Safety Biomarker (SAF): MTHFR
Study 35030476 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32351164 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 33771102 — Predictive Biomarker (PRD): PTBP2 mRNA
Genes: PTBP2; NPTB; PTB; PTBLP
Study 33771102 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 34725039 — Surrogate Endpoint (SUR): Blood pressure
Study 35341156 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 35341156 — Surrogate Endpoint (SUR): Serum creatinine
Study 35341156 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 616841197 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 616841197 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study 616841197 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 36041655 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study 36450458 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35445840 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 33599684 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34532895 — Predictive Biomarker (PRD): COMMD3 mRNA
Genes: COMMD3; BUP; C10orf8
Study 33301254 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 34512511 — Surrogate Endpoint (SUR): Blood pressure
Study 36307193 — Surrogate Endpoint (SUR): Blood pressure
Study 32249696 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Sclerostin
Genes: SOST; UNQ2976/PRO7455/PRO7476
Study 35700149 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35394456 — Predictive Biomarker (PRD): TLX2 mRNA
Genes: TLX2; HOX11L1; NCX
Study 35718979 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 32338063 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 32124422 — Predictive Biomarker (PRD): MCIDAS mRNA
Genes: MCIDAS; IDAS; MCI; MCIN
Study 33660033 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 36240478 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study 36240478 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study 36240478 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 34081408 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34300310 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34300310 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32325778 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35419807 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 33935055 — Predictive Biomarker (PRD): COPE mRNA
Genes: COPE
Study 33910419 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 32281095 — Surrogate Endpoint (SUR): Blood pressure
Study 33958243 — Surrogate Endpoint (SUR): Blood pressure
Study 34236392 — Surrogate Endpoint (SUR): Blood pressure
Study 34018344 — Safety Biomarker (SAF): DRD3
Study 32366963 — Predictive Biomarker (PRD): TFAP2B mRNA
Genes: TFAP2B
Study 32366963 — Predictive Biomarker (PRD): TCF7L2 mRNA
Genes: TCF7L2; TCF4
Study 32366963 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study 32441868 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32441868 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32441868 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33002731 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 33002731 — Safety Biomarker (SAF): BDNF
Study 35484369 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 33443913 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 32286894 — Surrogate Endpoint (SUR): Serum triglycerides
Study 32286894 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33572909 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35742753 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 35742753 — Safety Biomarker (SAF): BDNF
Study 35502600 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 35502600 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 32580480 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 35545122 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 32081489 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 34526086 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33921101 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 34635140 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32705829 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 32705829 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 32705829 — Predictive Biomarker (PRD): CORT mRNA
Genes: CORT; UNQ307/PRO350
Study 33016505 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 33114566 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 36131172 — Surrogate Endpoint (SUR): Blood pressure
Study 36036925 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 32684473 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 35831153 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 35831153 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36398123 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 32194058 — Monitoring Biomarker (MOI): Procalcitonin
Study 34855460 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 34823375 — Surrogate Endpoint (SUR): Blood pressure
Study 34263648 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 34263648 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34958359 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 616768357 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33481506 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 33097204 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 34496357 — Surrogate Endpoint (SUR): Blood pressure
Study 32068197 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34445995 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 33068293 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33068293 — Monitoring Biomarker (MOI): Procalcitonin
Study 33068293 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34587911 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34571050 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32387064 — Surrogate Endpoint (SUR): Blood pressure
Study 32387064 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32669450 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35902195 — Surrogate Endpoint (SUR): Blood pressure
Study 35761841 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35439521 — Safety Biomarker (SAF): Hyaluronic acid
Study 33736592 — Surrogate Endpoint (SUR): Bone mineral density
Study 35788824 — Surrogate Endpoint (SUR): Blood pressure
Study 34240673 — Surrogate Endpoint (SUR): Bone mineral density
Study 35125224 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 32267783 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 32267783 — Surrogate Endpoint (SUR): Blood pressure
Study 34237655 — Predictive Biomarker (PRD): SMO mRNA
Genes: SMO; SMOH
Study 34617955 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34617955 — Predictive Biomarker (PRD): Hormone receptor
Study 34867113 — Predictive Biomarker (PRD): ITK mRNA
Genes: ITK; EMT; LYK
Study 32563606 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study 34698676 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study 33186448 — Surrogate Endpoint (SUR): Blood pressure
Study 33901635 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 33901635 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 33901635 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35830482 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 33150514 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 34037282 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34037282 — Predictive Biomarker (PRD): Hormone receptor
Study 34056000 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34056000 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 34544205 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 34544205 — Surrogate Endpoint (SUR): Blood pressure
Study 35248295 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33070529 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study 32487558 — Surrogate Endpoint (SUR): Total kidney volume
Study 35968501 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34543871 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 35795140 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32473901 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32473901 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33966415 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 33150681 — Surrogate Endpoint (SUR): Blood pressure
Study 34311098 — Surrogate Endpoint (SUR): Blood pressure
Study 33875799 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 33875799 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33875799 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 33875799 — Safety Biomarker (SAF): Interleukin 12
Study 33875799 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33831216 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33852722 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study 616775801 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 616775801 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 616775801 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 616775801 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32091610 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study 35279741 — Predictive Biomarker (PRD): PDE4B mRNA
Genes: PDE4B; DPDE4